Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder

Drug and Alcohol Dependence
Elizabeth E KransMarian Jarlenski

Abstract

The purpose of this study was to describe postpartum contraceptive utilization patterns among women with OUD and evaluate the relationship between postpartum contraceptive method choice and interpregnancy interval. A retrospective cohort study was conducted with women in Pennsylvania Medicaid with a diagnosis of OUD between 2008 and 2013. Postpartum contraceptive use within 90 days after delivery was identified through claims data and categorized by effectiveness (highly-effective, effective, and no method observed). Kaplan-Meier time-to-event analyses and multivariable-adjusted marginal Cox regression models were used to evaluate the relationship between postpartum contraceptive method choice and interpregnancy interval. Multivariable logistic regression analyses were used to identify risk factors predictive of a short interpregnancy interval (≤18 months). We identified 7805 women (9260 pregnancies) who had a diagnosis of OUD. Nearly three-quarters (74.5%) had no contraceptive method observed, 18.1% received an effective method, and only 7.4% received a highly-effective method (LARC or female sterilization) during the postpartum period. In Kaplan-Meier analyses, no significant differences were found in the time-to-next pregnan...Continue Reading

References

Apr 20, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Annamarie ConnollyLaurie Pahel
Nov 26, 2005·Contraception·Joseph A Tony OgburnJody Stonehocker
Apr 20, 2006·JAMA : the Journal of the American Medical Association·Agustin Conde-AgudeloAna Cecilia Kafury-Goeta
Jun 15, 2007·Perspectives on Sexual and Reproductive Health·Jennifer J FrostLawrence B Finer
Dec 18, 2007·Contraception·Kathryn KostAkinrinola Bankole
Feb 6, 2010·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, UNKNOWN Long-Acting Reversible Contraception Working Group
Nov 3, 2010·Journal of Substance Abuse Treatment·Sarah H HeilPeter R Martin
Apr 12, 2011·Contraception·James Trussell
Apr 22, 2011·The New England Journal of Medicine·Kelly ClelandJames Trussell
Feb 18, 2012·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Kirsten I BlackNicholas Lintzeris
May 29, 2012·American Journal of Obstetrics and Gynecology·Kristina M TocceStephanie B Teal
Sep 22, 2012·Obstetrics and Gynecology·UNKNOWN Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetrician
Apr 3, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Maureen K Baldwin, Alison B Edelman
Jun 8, 2013·Obstetrics and Gynecology·Alison Gemmill, Laura Duberstein Lindberg
May 13, 2014·Contraception·Stephanie B Teal
Aug 6, 2014·American Journal of Obstetrics and Gynecology·Lauren B ZapataKathryn M Curtis
May 23, 2015·Obstetrics and Gynecology·Kari WhiteJoseph E Potter
Feb 16, 2016·American Journal of Obstetrics and Gynecology·Caitlin Parks, Jeffrey F Peipert
Mar 10, 2016·JAMA : the Journal of the American Medical Association·Juliana Tolles, Roger J Lewis
Mar 11, 2016·The New England Journal of Medicine·Lawrence B Finer, Mia R Zolna
Jul 28, 2016·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice
Dec 8, 2016·Obstetrics and Gynecology·Lisa G HoflerMelissa Kottke
Mar 7, 2017·American Journal of Obstetrics and Gynecology·Heike Thiel de BocanegraEleanor Bimla Schwarz

❮ Previous
Next ❯

Citations

Mar 26, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Briana P PattonMarian Jarlenski
Dec 23, 2020·Policy, Politics & Nursing Practice·Brayden N Kameg
Mar 23, 2020·Addictive Behaviors·Anna YermachenkoMaria Melchior
Aug 4, 2021·American Journal of Epidemiology·Abigail R CartusLisa M Bodnar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.